Neuroimaging in neuropsychiatry: Methods, possibilities and limits;Funkční zobrazovací metody V neuropsychiatrii: Metody, možnosti a omezení

Psychiatrie

Volumn 5, Issue 2, 2001, Pages 87-94

  Kopecek M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

dCT; fMR; Neuropsychiatry; PET; SPECT

Indexed keywords

1 METHYL 4 PIPERIDYL BENZILATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; ALTANSERIN; AMIDE; CARAZOLOL; CLORGYLINE; CYSTEINE ETHYL ESTER TC 99M; DIPRENORPHINE; EPIBATIDINE; EPIDEPRIDE; FLUMAZENIL; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IOMAZENIL; ISOREMOXIPRIDE; KETAMINE; NICOTINE; PIPERIDINE DERIVATIVE; PSYCHOTROPIC AGENT; QUINUCLIDINYL BENZILATE; R 91150; RACLOPRIDE; RADIOPHARMACEUTICAL AGENT; RO 43 0463; SELEGILINE; SETOPERONE; SPIPERONE; TACRINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BRAIN METABOLISM; BRAIN PERFUSION; COMPUTER ASSISTED TOMOGRAPHY; MENTAL DISEASE; NEUROPSYCHIATRY; NEURORADIOLOGY; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARDIZATION;

EID: 0034935530     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Playing with dopamine release
2. Remembering the past: Two facets of episodic memory explored with positron emission tomography
3. Cerebral perfusion inhomogeneities in schizophrenia demonstrated with single photon emission computed tomography and Tc99m- hexamethylpropyleneamineoxim
4. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls
5. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography
6. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia
7. Schizophrenia - A brain disease? A critical review of structural and functional cerebral abnormality in the disorder
8. Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: A SPECT study
9. On the speed of mental processes
10. Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients
11. Hypofrontality revisited: A high resolution single photon emission computed tomography study in schizophrenia
12. Active and remitted schizophrenia: Psychopathological and regional cerebral blood flow findings
13. Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters
14. Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia
15. Inhibition of monoamine oxidase B in the brains of smokers
16. Brain monoamine oxidase A inhibition in cigarette smokers
17. Nonoxidative glucose consumption during focal physiologic neural activity
18. The trouble with cognitive subtraction
19. Magnetická rezonanční spektroskopie v psychiatrii
20. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol
21. Comparison between the decrease of dopamine transporter and that of L- DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models
22. Funkční magnetická rezonance a evokované potenciály - Základní principy a aplikace
23. Cerebral blood flow and personality: A positron emission tomography study
24. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
25. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT
26. Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders
27. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
28. Vyšetření regionální mozkové perfuze pomocí jednofotonové emisní tomografie (SPECT) v psychiatrii
29. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET
30. Brain 6-[18F]fluorodopa metabolism in early and late onset of Parkinson's disease studied by positron emission tomography
31. Brain magnetic resonance imaging with contrast dependent on blood oxygenation
32. PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457
33. Functional imaging for disorders of basal ganglia
34. The resting and activation issue of hypofrontality: A single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients
35. Temporal lobe perfusion asymmetries in schizophrenia
36. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder
37. D2-dopamine receptor upregulation and treatment response under neuroleptic therapy
38. Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: An [123I]iodobenzamide single photon emission computed tomography study
39. Metabolic mapping of functional activity in the hypothalamo- neurohypophysial system of the rat
40. Are brain functions really additive?
41. High-resolution SPECT study of regional cerebral blood flow in drug- free and drug-naive schizophrenic patients
42. Gender differences in cerebellar metabolism: Test-retest reproducibility
43. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)
44. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis
45. Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET)
46. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man - A PET study with [11C]raclopride
47. Effects of (S)-ketamine on striatal dopamine: A [11C] raclopride PET study of a model psychosis in humans
48. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence
49. Quantification of neuroreceptors in the living human brain: III. D2- like receptors: Theory, validation, and changes during normal aging